|
|
Deep Brain Stimulation (DBS) For Severe Treatment Refractory Methamphetamine Use Disorder |
| 1UG3DA054746-01A1 |
|
NIDA |
2022 |
|
|
Facilitating supervised self-management of stimulant medications among adolescents: improving adherence, reducing stigma, and supporting caregivers |
| 3R43DA053121-01A1S1 |
|
NIDA |
2022 |
|
|
Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder |
| 4UH3DA047714-03 |
|
NIDA |
2022 |
|
|
Multi-level associations between opioid use and overdose: Individual, clinical, and population-based risk factors for fatality |
| 5K01DA049950-03 |
|
NIDA |
2022 |
|
|
Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders |
| 5R01DA017846-13 |
|
NIDA |
2022 |
|
|
Pathogenesis of Neuroinflammation and Neurocognitive Impairment In HIV-infected Young Adult Cannabis Users |
| 5R01DA048627-03 |
|
NIDA |
2022 |
|
|
A prospective examination of stimulant diversion and related risk factors for young adults with childhood- or adult-diagnosed ADHD |
| 5R01DA049721-03 |
|
NIDA |
2022 |
|
|
Changes in cognition and psychiatric disorder symptoms during cannabis abstinence using a novel discordant twin design |
| 1 K23 DA054212-01 |
ROSS, JESSICA MEGAN |
NIDA |
2021 |
|
|
Multi-level associations between opioid use and overdose: Individual, clinical, and population-based risk factors for fatality |
| 5 K01 DA049950-02 |
SAMPLES, HILLARY |
NIDA |
2021 |
|
|
Electroretinogram: a new human biomarker for smoking cessation treatment |
| 5 K23 DA042136-05 |
LUO, SEAN XIAO |
NIDA |
2021 |
